Comparison of Grip Test and TFI parameters depending on the sex of patients eligible for TAVI treatment
More details
Hide details
1
Klinika Kardiologii i Chorób Strukturalnych Serca, Górnośląskie Centrum Medyczne im. prof. Leszka Gieca Śląskiego Uniwersytetu Medycznego w Katowicach / Department of Cardiology and Structural Heart Diseases, Leszek Giec Upper-Silesian Medical Centre of the Medical University of Silesia, Katowice, Poland
Corresponding author
Piotr Godek
Klinika Kardiologii i Chorób Strukturalnych Serca, Górnośląskie Centrum Medyczne im. prof. Leszka Gieca, ul. Ziołowa 45/47, 40-635 Katowice
Ann. Acad. Med. Siles. 2024;78:82-88
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Severe aortic stenosis has become one of those diseases that pose a significant clinical problem in aging societies in recent years. One of the therapeutic options for patients with such a diagnosis has become the transcatheter aortic valve implantation (TAVI).
Material and methods:
In the group of patients (n = 92) treated for aortic stenosis in Leszek Giec Upper-Silesian Medical Centre of the Medical University of Silesia in Katowice, qualified by the heart team for TAVI treatment, muscle strength was assessed and the probability of frailty syndrome in the study group was assessed. The study group was further divided by gender to compare the incidence of frailty syndrome and the distribution of reference values of muscle strength measurements depending on this factor.
Results:
The median muscle strength measured by the Grip Test was 26.8 kg. These values, combined with data from the Tilburg Frailty Indicator (TFI) test, indicated significant fragility among the sample. The median TFI score was 8 pts, indicating a high level of fragility. Cardiac function, as measured by ejection fraction (EF), was 55%, which was within normal limits, suggesting moderate heart function among the subjects. The median glomerular filtration rate (GFR) was 62.5 ml/min/1.73 m2, which also suggested moderate renal function among the participants.
Conclusions:
The results presented in the paper in relation to frailty syndrome determined by the TFI test showed that the vast majority of the subjects (94.6%) exhibited frailty syndrome. A deeper analysis of the TFI results showed that almost 60% of the subjects had up to 5 pts (mild degree of fragility), while 27.5% had a score above 10 pts (severe degree of fragility).
REFERENCES (13)
1.
Seiffert P., Maślanka-Seiffert B., Derejczyk J., Marcisz Cz. Frailty – narzędzia diagnostyczne stosowane w praktyce klinicznej. Geriatria 2018; 12: 142–149.
2.
Zasadzka E., Strzesak D., Poterska A., Trzmiel T., Pawlaczyk M. Siła uścisku ręki u osób po 65 roku życia. Geriatria 2017; 11: 117–122.
3.
R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing. Vienna, Austria 2023 [online]
https://www.R-project.org/ [dostęp: 26.11.2023].
4.
Makowski D., Lüdecke D., Patil I., Thériault R., Ben-Shachar M., Wiernik B. Automated results reporting as a practical tool to improve reproducibility and methodological best practices adoption. CRAN 2023 [online]
https://easystats.github.io/re... [dostęp: 26.11.2023].
5.
Patil I. Visualizations with statistical details: The ‘ggstatsplot’ approach. JOSS 2021; 6(61): 3167, doi: 10.21105/joss.03167.
6.
Sjoberg D.D., Whiting K., Curry M., Lavery J.A., Larmarange J. Reproducible summary tables with the gtsummary package. The R Journal 2021; 13(1): 570–580, doi: 10.32614/RJ-2021-053.
8.
Ben-Shachar M.S., Lüdecke D., Makowski D. effectsize: Estimation of effect size indices and standardized parameters. JOSS 2020; 5(56): 2815, doi: 10.21105/joss.02815.
9.
Wickham H., François R., Henry L., Müller K., Vaughan D. Dplyr: A Grammar of Data Manipulation. R package version 1.1.3, 2023 [online]
https://CRAN.R-project.org/pac... [dostęp: 26.11.2023].
10.
Vahanian A., Beyersdorf F., Praz F., Milojevic M., Baldus S., Bauersachs J. et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur. Heart J. 2022; 43(7): 561–632, doi: 10.1093/eurheartj/ehab395.
11.
Baritello O., Salzwedel A., Sündermann S.H, Niebauer J., Völler H. The Pandoraʼs box of frailty assessments: which is the best for clinical purposes in TAVI patients? A critical review. J. Clin. Med. 2021; 10(19): 4506, doi: 10.3390/jcm10194506.
12.
Brown A.D., Li B., Gabriel S., Cusimano R.J., Chung J., Horlick E. et al. Association between sarcopenia and adverse events following transcatheter aortic valve implantation. CJC Open 2021; 4(2): 173–179, doi: 10.1016/j.cjco.2021.09.012.
13.
Godek P. Ocena zasobów poznawczych chorych ze stenozą aortalną kwalifikowanych do leczenie metodą TAVI – przydatność kliniczna. Geriatria 2022; 16: 87–90.